Form 8-K 23andMe Holding Co. For: Jun 03
FREE Breaking News Alerts from StreetInsider.com!
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Citi Reiterates Neutral Rating on 23andMe Holding (ME)
June 3, 2024 3:17 PM EDTCiti analyst Daniel Grosslight reiterated a Neutral rating and $0.63 price target on 23andMe Holding (NASDAQ: ME).
The analyst comments "At the 2024 American Society of Clinical Oncology (ASCO) meeting, 23andMe presented early Ph2 data (as part of its ongoing Ph1/2a trial) for... More
